Takeda Pharmaceutical Ltd ADR (TAK)
14.98 x 3 15.02 x 2
Post-market by (Cboe BZX)
15.02 -0.02 (-0.13%) 03/26/25 [NYSE]
14.98 x 3 15.02 x 2
Post-market 15.02 unch (unch) 16:11 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2020 | |
| Sales | 29,419,960 | 29,803,340 | 31,764,150 | 30,059,430 | 30,278,930 |
| Cost of Goods | 9,844,078 | 9,206,133 | 9,850,930 | -9,346,495 | 10,025,830 |
| Gross Profit | 19,575,880 | 20,597,210 | 21,913,220 | 39,405,930 | 20,253,100 |
| Operating Expenses | 18,098,830 | 16,967,590 | 17,812,630 | 15,925,314 | 19,330,180 |
| Operating Income | 1,477,118 | 3,629,737 | 4,101,512 | 4,787,128 | 923,754 |
| Interest Expense | 1,516,965 | 1,255,765 | 1,482,802 | 2,337,131 | 1,518,055 |
| Other Income | 404,105 | 401,694 | 74,172 | 992,612 | 35,365 |
| Pre-tax Income | 364,258 | 2,775,666 | 2,692,882 | 3,442,609 | -558,937 |
| Income Tax | -630,701 | 429,585 | 644,405 | -93,398 | -966,405 |
| Net Income Continuous | 994,959 | 2,346,081 | 2,048,477 | 3,536,007 | 407,468 |
| Minority Interests | 897 | 155 | 952 | 1,560 | 451 |
| Net Income | $994,062 | $2,345,926 | $2,047,525 | $3,534,447 | $407,017 |
| EPS Basic Total Ops | 0.32 | 0.76 | 0.65 | 1.13 | 0.13 |
| EPS Basic Continuous Ops | 0.32 | 0.76 | 0.66 | 1.13 | 0.13 |
| EPS Diluted Total Ops | 0.31 | 0.75 | 0.65 | 1.12 | 0.13 |
| EPS Diluted Continuous Ops | 0.31 | 0.75 | 0.65 | 1.12 | 0.13 |
| EPS Diluted Before Non-Recurring Items | 1.67 | 2.07 | 1.89 | 1.98 | 1.78 |
| EBITDA(a) | $6,500,339 | $8,546,307 | $9,291,565 | $28,741,030 | $6,293,325 |